Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-22 4:22 pm Purchase | 2026-04-20 | 13D | PRELUDE THERAPEUTICS INC PRLD | Baker Bros. Advisors LP | 10,295,301 15.500% | 25,333 (+0.25%) | Filing History |
| 2026-04-16 4:32 pm Sale | 2026-04-16 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 115,918,313 8.000% | -9,358,297 (-7.47%) | Filing History |
| 2026-03-24 4:06 pm Purchase | 2026-03-20 | 13D | CELCUITY INC CELC | Baker Bros. Advisors LP | 9,582,874 19.990% | 1,837,182 (+23.72%) | Filing History |
| 2026-02-26 6:59 pm Purchase | 2026-02-24 | 13D | ACADIA PHARMACEUTICALS INC ACAD | Baker Bros. Advisors LP | 43,294,373 25.400% | 66,774 (+0.15%) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-12-31 | 13G | GRAIL INC GRAL | Baker Bros. Advisors LP | 2,085,333 5.300% | 2,085,333 (New Position) | Filing History |
| 2026-02-17 4:25 pm Purchase | 2025-12-31 | 13G | ALKERMES PLC ALKS | Baker Bros. Advisors LP | 10,012,267 6.100% | 10,012,267 (New Position) | Filing History |
| 2026-02-17 4:20 pm Purchase | 2025-12-31 | 13G | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 2,890,055 9.990% | 2,145,296 (+288.05%) | Filing History |
| 2026-02-17 4:19 pm Purchase | 2025-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | Baker Bros. Advisors LP | 9,455,357 4.900% | 90,385 (+0.97%) | Filing History |
| 2026-02-17 4:16 pm Purchase | 2025-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Baker Bros. Advisors LP | 7,527,996 7.200% | 776,431 (+11.50%) | Filing History |
| 2026-02-17 4:13 pm Sale | 2025-12-31 | 13G | STOKE THERAPEUTICS INC STOK | Baker Bros. Advisors LP | 3,336,697 5.800% | -1,031,746 (-23.62%) | Filing History |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Baker Bros. Advisors LP | 4,345,736 6.700% | -570,359 (-11.60%) | Filing History |
| 2026-02-10 6:31 pm Purchase | 2026-02-06 | 13D | INCYTE CORPORATION INCY | Baker Bros. Advisors LP | 31,213,417 15.700% | 3,521 (+0.01%) | Filing History |
| 2026-01-14 5:36 pm Purchase | 2026-01-12 | 13D | DBV TECHNOLOGIES S.A. ADR DBVT | Baker Bros. Advisors LP | 25,586,190 9.990% | 2,096,527 (+8.93%) | Filing History |
| 2025-12-19 4:22 pm Purchase | 2025-12-18 | 13D | KODIAK SCIENCES INC KOD | Baker Bros. Advisors LP | 20,067,542 32.800% | 2,713,696 (+15.64%) | Filing History |
| 2025-12-11 5:27 pm Purchase | 2025-12-09 | 13D | KYMERA THERAPEUTICS INC KYMR | Baker Bros. Advisors LP | 8,676,797 10.900% | 2,010,257 (+30.15%) | Filing History |
| 2025-11-14 4:25 pm Purchase | 2025-09-30 | 13G | IMMATICS N V IMTX | Baker Bros. Advisors LP | 12,094,094 9.950% | 1,925,193 (+18.93%) | Filing History |
| 2025-11-14 4:24 pm Sale | 2025-09-30 | 13G | CERUS CORP CERS | Baker Bros. Advisors LP | 10,028,209 5.200% | -2,875,499 (-22.28%) | Filing History |
| 2025-10-03 09:06 am Unchanged | 2025-10-02 | 13G | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 744,759 9.990% | 0 (Unchanged) | Filing History |
| 2025-10-02 8:37 pm Sale | 2025-09-30 | 13D | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 744,759 9.990% | -457,135 (-38.03%) | Filing History |
| 2025-08-18 5:52 pm Sale | 2025-08-14 | 13D | IGM BIOSCIENCES INC IGMS | Baker Bros. Advisors LP | 0 0.000% | -4,145,706 (Position Closed) | Filing History |